Department of Biomedical and Chemical Engineering, Syracuse University, Syracuse, NY 13244, USA.
Spine J. 2011 May;11(5):432-9. doi: 10.1016/j.spinee.2011.02.012. Epub 2011 Apr 11.
Previous ex vivo studies showed that the properties of commercial cements modified for use in vertebroplasty are not optimal and are associated with several drawbacks, including high exothermic reaction, low cement viscosity and consequent extravasation, and unpredictable wait time after cement preparation. Additionally, strength and stiffness restoration are controversial varying with the cement type, volume injected, and technique used.
To investigate maximum polymerization temperatures and mechanical performance of novel two-solution bone cement (TSBC) modified by the addition of cross-linked poly(methyl methacrylate) nanospheres (η-TSBC) and microspheres (μ-TSBC) in a cadaver vertebroplasty model in comparison to a commercially available cement (KyphX). To study the viability of application of these novel cement formulations in the treatment of vertebral compression fractures.
STUDY DESIGN/SETTING: Ex vivo biomechanical and exothermal evaluation of TSBCs using cadaveric vertebral bodies (VBs).
Thirty-one cadaveric vertebrae (age, 74±2 years; T score, -1.5±0.5) were disarticulated. Thirteen vertebrae were assigned into three groups and instrumented with thermocouples positioned midbody along the intersection of the midsagittal and midcoronal axes, as well as along the intersection of the midsagittal axis and posterior VB wall. After equilibration at 37°C, 5 mL of cement was injected and temperatures were recorded for 1 hour. The groups were injected with η-TSBC, μ-TSBC, or KyphX. The remaining 18 vertebrae were biomechanically tested. After randomization into three groups, each specimen was fractured in compression and stabilized with 5 mL of each cement type. Each specimen was then retested in axial compression.
Temperatures in the central region of the vertebrae were significantly lower (p<.05) when injected with η-TSBC (44°C) in comparison to KyphX (75°C) and μ-TSBC (64°C). A significant difference was not detected between the pre- and postcementing strength (p>.05) of the three groups. There was no significant difference between the average values of stiffness among the cements (p>.05), however there was a significant difference between intact and treated stiffness (p<.05).
The TSBC cements decreased the local temperature within the VB while providing similar mechanical strength when compared with vertebrae treated with KyphX.
先前的离体研究表明,经改良用于椎体成形术的商业水泥的性能并不理想,并且存在多种缺点,包括高热反应、低水泥粘度和随之而来的渗漏,以及在水泥准备后等待时间不可预测。此外,强度和刚度的恢复因水泥类型、注射量和使用的技术而异而存在争议。
在尸体椎体成形术模型中,通过添加交联聚甲基丙烯酸甲酯纳米球(η-TSBC)和微球(μ-TSBC)来研究新型双溶液骨水泥(TSBC)的最大聚合温度和力学性能,并与市售水泥(KyphX)进行比较。研究这些新型水泥配方在治疗椎体压缩性骨折中的应用的可行性。
研究设计/设置:使用尸体椎体(VB)进行离体生物力学和放热评价。
31 个尸体椎体(年龄 74±2 岁;T 评分-1.5±0.5)被分离。13 个椎体被分为三组,并在体中部沿着中矢状和中冠状轴的交点以及中矢状轴和椎体后壁的交点放置热电偶。在 37°C 下平衡后,注入 5 mL 水泥并记录 1 小时的温度。三组分别注入 η-TSBC、μ-TSBC 或 KyphX。其余 18 个椎体进行生物力学测试。随机分为三组后,每个标本在压缩下骨折,并使用每种水泥类型 5 mL 稳定。然后,每个标本在轴向压缩下进行重新测试。
与 KyphX(75°C)和 μ-TSBC(64°C)相比,注入 η-TSBC 时椎体中央区域的温度明显降低(p<.05)。三组间水泥前后强度无显著差异(p>.05)。三种水泥的刚度平均值无显著差异(p>.05),但完整椎体和治疗后椎体的刚度有显著差异(p<.05)。
与用 KyphX 治疗的椎体相比,TSBC 水泥在降低 VB 内局部温度的同时提供了相似的机械强度。